Accuray Incorporated (ARAY)
 NASDAQ: ARAY · Real-Time Price · USD
 1.380
 -0.060 (-4.17%)
  At close: Oct 30, 2025, 4:00 PM EDT
1.390
 +0.010 (0.72%)
  After-hours: Oct 30, 2025, 6:45 PM EDT
Accuray Revenue
In the fiscal year ending June 30, 2025, Accuray had annual revenue of $458.51M with 2.68% growth. Accuray had revenue of $127.54M in the quarter ending June 30, 2025, a decrease of -5.02%.
Revenue (ttm) 
 $458.51M
Revenue Growth 
 +2.68%
P/S Ratio 
 0.31
Revenue / Employee 
 $463,136
Employees 
 990
Market Cap 
155.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Jun 30, 2025 | 458.51M | 11.95M | 2.68% | 
| Jun 30, 2024 | 446.55M | -1.05M | -0.24% | 
| Jun 30, 2023 | 447.61M | 17.70M | 4.12% | 
| Jun 30, 2022 | 429.91M | 33.62M | 8.48% | 
| Jun 30, 2021 | 396.29M | 13.36M | 3.49% | 
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| UnitedHealth Group | 435.16B | 
| Johnson & Johnson | 92.15B | 
| Merck & Co. | 64.24B | 
| Eli Lilly and Company | 59.42B | 
| AbbVie | 58.33B | 
| AstraZeneca | 56.50B | 
| Novartis AG | 56.37B | 
| Novo Nordisk | 49.11B | 
ARAY News
- 2 days ago - Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025 - PRNewsWire
- 10 days ago - Accuray Accelerates Transformation Efforts with Appointment of Experienced Executive Leaders to Drive Performance and Growth - PRNewsWire
- 22 days ago - Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System - PRNewsWire
- 4 weeks ago - Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care - PRNewsWire
- 4 weeks ago - Accuray Incorporated (ARAY) Shareholder/Analyst Call Transcript - Seeking Alpha
- 4 weeks ago - Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care - PRNewsWire
- 7 weeks ago - Accuray to Host Analyst Event at the American Society of Radiation Oncology Meeting on September 29, 2025 - PRNewsWire
- 2 months ago - Accuray Incorporated (ARAY) Q4 2025 Earnings Call Transcript - Seeking Alpha